Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. AVITA Medical, Inc.
  6. News
  7. Summary
    AVH   AU000000AVH4

AVITA MEDICAL, INC.

(AVH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

AVITA Medical : Notification regarding unquoted securities - AVH

12/05/2021 | 05:12pm EST

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

use only

Entity name

AVITA MEDICAL INC.

Date of this announcement

Monday December 06, 2021

The +securities the subject of this notification are:

Unquoted options that have been exercised or other unquoted +convertible securities that have been converted

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

AVHAY

COMMON STOCK

625

30/11/2021

For personal

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

AVITA MEDICAL INC.

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ABN

28058466523

1.3

ASX issuer code

AVH

  1. The announcement is New announcement
  2. Date of this announcement

6/12/2021

Notification of Issue, Conversion or Payment up of Unquoted

2 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

Unquoted options that have been exercised or other unquoted +convertible securities that have been converted

For personal use only

2.2b The +securities being issued, transferred or re-classified as a result of the options being exercised or other +convertible securities being converted are:

in a class which is not quoted on ASX but which has an existing ASX security code ("existing class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B

only

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

A reclassification of the +convertible securities as securities in the same class as the +underlying securities

The underlying securities being received by the holder are:

Are not, and are not intended to be, quoted by ASX

Existing +securities converting into an existing class

FROM (Existing Class)

ASX +Security code and description

AVHAE : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

use

TO (Existing Class)

ASX +Security code and description

AVHAY : COMMON STOCK

Please state the number of options that were exercised or other +convertible securities that were converted

62,500

The first date the options were exercised or other +convertible securities were converted

30/11/2021

The last date the options were exercised or other +convertible securities were converted

30/11/2021

For personal

Is this all of the options or other +convertible securities on issue of that type?

No

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?

No

Date the +securities the subject of this notification were issued/transferred

30/11/2021

Will the +securities rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

Any other information the entity wishes to provide about the +securities the subject of this notification

Notification of Issue, Conversion or Payment up of Unquoted

4 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Issue details

Number of +securities

625

For personal use only

Notification of Issue, Conversion or Payment up of Unquoted

5 / 8

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Avita Therapeutics Inc. published this content on 05 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 December 2021 22:11:04 UTC.


ę Publicnow 2021
All news about AVITA MEDICAL, INC.
01/11AVITA MEDICAL : Notification regarding unquoted securities - AVH
PU
01/11AVITA MEDICAL : Announces Preliminary Unaudited Results for the Quarter ended December 31,..
PU
01/11AVITA MEDICAL, INC. : Results of Operations and Financial Condition, Regulation FD Disclos..
AQ
01/11AVITA MEDICAL : Corporate Deck January 2022
PU
01/11Avita Medical's Revenue Jumps 35% in Q4 2021; Completes Recruitment for Clinical Trials
MT
01/10AVITA MEDICAL : JP Morgan Healthcare Conference Presentation
PU
01/10AVITA Medical Announces Preliminary Unaudited Results for the Quarter ended December 31..
AQ
01/10AVITA Medical, Inc. Reports Preliminary Unaudited Revenue Results for the Quarter Ended..
CI
01/07Avita Medical Completes Enrollment in Soft-Tissue Reconstruction Study
MT
01/06Avita Medical Establishes Proof of Concept for Cell-based Gene Therapy Treatments
MT
More news
Analyst Recommendations on AVITA MEDICAL, INC.
More recommendations
Financials
Sales 2022 41,9 M 30,2 M 30,2 M
Net income 2022 -44,6 M -32,2 M -32,2 M
Net cash 2022 96,7 M 69,7 M 69,7 M
P/E ratio 2022 -2,96x
Yield 2022 -
Capitalization 364 M 263 M 262 M
EV / Sales 2022 6,38x
EV / Sales 2023 5,34x
Nbr of Employees 108
Free-Float 98,1%
Chart AVITA MEDICAL, INC.
Duration : Period :
AVITA Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVITA MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 2,92 AUD
Average target price 7,69 AUD
Spread / Average Target 163%
EPS Revisions
Managers and Directors
Michael S. Perry Chief Executive Officer & Executive Director
Michael B. Holder Chief Financial Officer
Louis James Panaccio Non-Executive Chairman
Andrew Quick Chief Technology Officer
Kathy McGee Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
AVITA MEDICAL, INC.-14.62%263
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684